Pork

The Pork MDL has been consolidated in the District of Minnesota since mid-2021, which means the claim files behind most of the 51 actions currently pending there reflect years of coordinated fact and expert discovery rather than a docket still finding its footing. For a funder or capital desk evaluating exposure to this litigation, that maturity is the starting point: pricing a claim against a pork-purchaser action here is a different exercise than pricing a claim in a docket centralized eighteen months ago, because the underlying record — pricing data, defendant document productions, economic modeling of the alleged overcharge — has had time to develop even where the public docket doesn't show every step.

For a law firm holding a meaningful book of direct-purchaser or indirect-purchaser claims arising out of pork-industry pricing conduct, the funding question is less about any single case and more about portfolio construction: how many claims sit in this docket relative to the firm's other protein-sector inventory (this litigation runs alongside comparable beef and chicken pricing dockets), what stage each cohort has reached, and how correlated the outcomes are likely to be given that all claims trace back to a common alleged information-sharing theory across defendants. Commercial claim funding and inventory finance under Criterica Capital's commercial litigation finance program are built for exactly that kind of cross-claim portfolio analysis rather than single-case underwriting, and a firm managing a multi-plaintiff book in this MDL should expect any funding structure to price the correlation, not just the count.

Because the plaintiff pool here is composed of businesses that purchased pork products — distributors, retailers, foodservice operators — rather than injured individuals, there is no medical-lien dimension to this docket's funding conversation; the relevant collateral is the commercial claim itself and the evidentiary record supporting the alleged overcharge. Structuring around this MDL's particular procedural posture also matters for duration risk: funding terms should reflect how much runway remains before any global resolution mechanism could return proceeds, not a generic assumption about MDL timelines. A structural and litigation-specific brief on this docket is also available through Criterica Intelligence for firms that want the procedural read alongside the funding conversation.

Pre-settlement funding is a non-recourse purchase of a portion of the proceeds of a pending legal claim — not a loan. If the case does not result in a recovery, nothing is owed. Rates, fees, and repayment terms are disclosed in full in the funding agreement, which the applicant’s attorney reviews before signing. Availability and terms vary by state.